The accessibility and equitable distribution of GLP-1 receptor agonists remain challenging with high costs, limited insurance coverage, and geographic disparities creating barriers to access, particularly affecting those in healthcare deserts or demographics with lower healthcare outcomes (Azizi et al., 2024
The All of Us research program systematically maps the international code of diseases to standardized SNOMED concepts
Redox metabolism abnormalities in autistic children associated with mitochondrial disease
Enter, the Allure Ingredient Index
The cellular foci may be relatively devoid of pigment synthesis, the foci of prominent pigment synthesis being identified in the more hypocellular blue nevus-like areas
Unlike compounds designed for direct therapeutic outcomes, BPC-157 peptide serves strictly as a research tool